Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

AbbVie and Shire in Talks Over $53 Billion Merger

14/07/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzmvmjyvntm3l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0


The Irish drug maker Shire said on Monday that its board was prepared to recommend an improved takeover bid received over the weekend from AbbVie, pending further discussions, paving the way for a merger.

In its latest bid, AbbVie, based in Chicago, has offered to pay cash and stock equal to about 53.20 pounds a share for Shire. That is the equivalent of roughly £31 billion, or about $53 billion.

AbbVie, the maker of the arthritis drug Humira, had previously offered to pay about $51 billion for Shire, which makes Vyvanse and Adderall XR, treatments for attention deficit hyperactivity disorder.

The deal, if completed, would allow AbbVie to reincorporate in Britain and save millions of dollars in taxes in a process known as an inversion. Shire has its headquarters in Ireland and is listed in London.

“The board of Shire has indicated to AbbVie that it would be willing to recommend an offer at the level of the revised proposal to Shire shareholders subject to satisfactory resolution of the other terms of the offer,” Shire said in a statement on Monday. “The board is in detailed discussions with AbbVie in relation to these terms.”

The health care sector has been one of the most active for deals this year, with an estimated $328.8 billion announced through July 10 – a 207 percent increase from the period a year earlier, according to Thomson Reuters.

Pharmaceutical companies in particular have been eager to take advantage of inversions, in which they reincorporate outside the United States to lower their corporate taxes and free up money that has been trapped overseas.

This article has been extracted from http://dealbook.nytimes.com, please click on this link to read the article in full http://dealbook.nytimes.com/2014/07/14/shire-and-abbvie-in-talks-over-53-billion-pharmaceutical-merger/?_php=true&_type=blogs&_r=0

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdgvmtqvmtmvmjcvmjgvnja2l2nsb3rozxmuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

In Her Shoes... From Market Stall to Recruitment

2017-08-14 14:00:00 +0100

From the melee of the market stall to placing candidates in high-flying IT roles, life's always on the up from market-trader-turned-recruiter, Lois Hinken (22). She took the time to talk to us about how her experience in the cut throat world of the market has helped her in the world of global talent acquisition. As a 360 recruitment consultant for Montash, her negotiation skills and "go get it" attitude have helped her thrive. "I started working on the ...

W1siziisijiwmtcvmdgvmdcvmtmvmtcvntqvnze3l1vudgl0bgvkigrlc2lnbiaomikuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

Will AI Cost Us Our Humanity?

2017-08-07 15:00:00 +0100

As technology evolves, artificial intelligence is becoming increasingly mainstream, and it will inevitably start to impact the way we interact. On the one hand, AI has the potential to solve a variety of problems and streamline our lives and our work. But will this come at the cost of the all-important human touch? A foreshadowing statistic claims that by 2020, 85% of client interactions will be managed without a human[1]. But can there really be an alg...